Israel Englander Calliditas Therapeutics Ab Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$26.02 - $31.17 $405,131 - $485,316
-15,570 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$27.01 - $32.92 $132,727 - $161,768
-4,914 Reduced 23.99%
15,570 $430,000
Q4 2020

Feb 16, 2021
SELL
$23.34 - $36.65 $413,981 - $650,061
-17,737 Reduced 46.41%
20,484 $696,000
Q3 2020

Nov 16, 2020
SELL
$21.61 - $25.69 $281,880 - $335,100
-13,044 Reduced 25.44%
38,221 $917,000
Q2 2020

Aug 14, 2020
BUY
$19.17 - $23.2 $982,750 - $1.19 Million
51,265 New
51,265 $1.19 Million

Others Institutions Holding CALT

# of Institutions
2
Shares Held
1.84K
Call Options Held
0
Put Options Held
0
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.06B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email